MedicineWorld.Org
Your gateway to the world of medicine
Home
News
Cancer News
About Us
Cancer
Health Professionals
Patients and public
Contact Us
Disclaimer

Medicineworld.org: New way to diagnose Alzheimer's disease

Back to neurology news Blogs list Cancer blog  


Subscribe To Neurology News RSS Feed  RSS content feed What is RSS feed?

New way to diagnose Alzheimer's disease




Physicians may be able to detect and treat Alzheimers Disease (AD) in its earliest stages, when patients are experiencing only mild degrees of cognitive impairment, thanks to new diagnostic criteria proposed by an international group of researchers.

Published in Lancet Neurology, the development of new guidelines was co-led by Dr. Howard Feldman, head of the Div. of Neurology in the University of British Columbias Faculty of Medicine.

Feldman, who directs the Clinic for Alzheimers Disease and Related Disorders at Vancouver Coastal Health, co-authored the paper with French researcher Dr. Bruno Dubois and researchers from countries that include Japan, the U.S. and England. Feldman is a member of Vancouver Coastal Health Research Institute (VCHRI).



New way to diagnose Alzheimer's disease

The proposed criteria are based on examining the structure and function of the brain using advanced brain imaging techniques as well as looking at spinal fluid for the imprint of the disease. Early detection will allow scientists to test vaccines that might be used preventively or to treat fully affected individuals, or other drug therapys that are directed at the earliest stages of the disease the best time to reduce symptoms.

Existing criteria, established in 1984, involve a two-step approach of evaluating functional disability and then looking for a cause, meaning diagnosis and therapy is delayed until patients have significant dementia symptoms.

Integrating the profound neurobiological advances of the last 20 years allow for diagnoses based on more than declining functional ability, says Feldman, a senior investigator with the Brain Research Centre (BRC) at UBC Hospital. We now have advanced diagnostic tools distinctive and reliable biological indicators that can be detected before the patient crosses the dementia threshold of disability.

The new criteria the scientists are proposing to the scientific community via the article represent a significant shift and will direct researchers and clinicians to a different focus than has been pursued over the last decade, he adds.

New diagnostic measures include a clinical core of early, progressive and significant episodic memory loss plus one or more abnormal biomarkers (biological indicators) characteristic of AD, including atrophy (wasting) of the temporal lobe as shown on Magnetic Resonance Imaging; abnormal amyloid Beta protein concentrations in the cerebrospinal fluid; a specific pattern showing reduced glucose metabolism on Positron Emission Tomography scans of the brain; and a genetic mutation for AD within the immediate family.

AD is a neurodegenerative disease characterized by progressive cognitive deterioration and is the most common form of dementia. The Alzheimer Society of Canada estimates that the disease affects more than 238,000 Canadians and that by 2031 about 750,000 Canadians will suffer from AD and related dementias. Approximately $5.5 billion per year is spent caring for persons with AD and related dementias in Canada. The Alzheimers Association in the U.S. estimates there are approximately 500,000 Americans younger than 65 with Alzheimers or other dementia.

Validation studies are needed to further explore the criteria and improve their sensitivity, specificity and accuracy, say the researchers.


Posted by: Daniel    Source




Did you know?
Physicians may be able to detect and treat Alzheimers Disease (AD) in its earliest stages, when patients are experiencing only mild degrees of cognitive impairment, thanks to new diagnostic criteria proposed by an international group of researchers. Published in Lancet Neurology, the development of new guidelines was co-led by Dr. Howard Feldman, head of the Div. of Neurology in the University of British Columbias Faculty of Medicine.

Medicineworld.org: New way to diagnose Alzheimer's disease

Acute bacterial meningitis| Alzheimer's disease| Carpal tunnel syndrome| Cerebral aneurysms| Cerebral palsy| Chronic fatigue syndrome| Cluster headache| Dementia| Epilepsy seizure disorders| Febrile seizures| Guillain barre syndrome| Head injury| Hydrocephalus| Neurology| Insomnia| Low backache| Mental retardation| Migraine headaches| Multiple sclerosis| Myasthenia gravis| Neurological manifestations of aids| Parkinsonism parkinson's disease| Personality disorders| Sleep disorders insomnia| Syncope| Trigeminal neuralgia| Vertigo|

Copyright statement
The contents of this web page are protected. Legal action may follow for reproduction of materials without permission.